国药一致(000028.SZ):国大药房成功摘牌成大方圆100%股权转让项目 成交价18.6亿元
格隆汇 7 月 24日丨国药一致(000028.SZ)公布,辽宁成大将其持有的成大方圆医药集团有限公司(以下简称“成大方圆”或“标的公司”)100%股权在大连产权交易所公开挂牌转让,公开挂牌转让底价为186,000万元人民币。
2020年7月24日,国大药房已成功摘牌成大方圆100%股权转2020年7月20日,国药集团一致药业股份有限公司召开第八届董事会第十八次会议,审议通过了《关于国药控股国大药房有限公司拟摘牌收购成大方圆医药集团有限公司100%股权的议案》,同意国药控股国大药房有限公司(以下简称“国大药房”)办理进场摘牌事宜。
2020年7月24日,国大药房已成功摘牌成大方圆100%股权转让项目,成交价格为人民币186,000万元。同日,国大药房与辽宁成大签署了《产权交易合同》。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.